- 関
- アミノカプロン酸
- 同
- Amicar
WordNet
- street name for lysergic acid diethylamide (同)back breaker, battery-acid, dose, dot, Elvis, loony toons, Lucy in the sky with diamonds, pane, superman, window pane, Zen
- any of various water-soluble compounds having a sour taste and capable of turning litmus red and reacting with a base to form a salt
- having the characteristics of an acid; "an acid reaction"
PrepTutorEJDIC
- 酸性の / 酸味のある,すっぱい(sour) / (言葉・態度などが)厳しい,しんらつな / 酸 / すっぱいもの / 《俗》=LSD
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2013/04/12 13:35:52」(JST)
[Wiki en表示]
|
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (October 2012) |
Aminocaproic acid
|
Systematic (IUPAC) name |
6-aminohexanoic acid |
Clinical data |
Trade names |
Amicar |
AHFS/Drugs.com |
monograph |
MedlinePlus |
a608023 |
Pregnancy cat. |
? |
Legal status |
℞ Prescription only |
Pharmacokinetic data |
Metabolism |
Renal |
Half-life |
2 hours |
Identifiers |
CAS number |
60-32-2 Y |
ATC code |
B02AA01 |
PubChem |
CID 564 |
DrugBank |
DB00513 |
ChemSpider |
548 Y |
UNII |
U6F3787206 Y |
KEGG |
D00160 Y |
ChEBI |
CHEBI:16586 Y |
ChEMBL |
CHEMBL1046 Y |
NIAID ChemDB |
018631 |
Chemical data |
Formula |
C6H13NO2 |
Mol. mass |
131.173 g/mol |
|
InChI
-
InChI=1S/C6H13NO2/c7-5-3-1-2-4-6(8)9/h1-5,7H2,(H,8,9) Y
Key:SLXKOJJOQWFEFD-UHFFFAOYSA-N Y
|
Y (what is this?) (verify)
|
Aminocaproic acid (also known as Amicar, ε-aminocaproic acid, ε-Ahx, or 6-aminohexanoic acid) is a derivative and analogue of the amino acid lysine, which makes it an effective inhibitor for enzymes that bind that particular residue. Such enzymes include proteolytic enzymes like plasmin, the enzyme responsible for fibrinolysis. For this reason it is effective in treatment of certain bleeding disorders, and it is marketed as Amicar. Aminocaproic acid is also an intermediate in the polymerization of Nylon-6, where it is formed by ring-opening hydrolysis of caprolactam.
Clinical use
Aminocaproic acid is used to treat excessive postoperative bleeding, especially after procedures in which a great amount of bleeding is expected, such as cardiac surgery. It can be given orally or intravenously. A meta-analysis found that lysine analogs like aminocaproic acid significantly reduced blood loss in patients undergoing coronary artery bypass grafting.
Aminocaproic acid can also be used to treat the overdose and/or toxic effects of the thrombolytic pharmacologic agents tissue plasminogen activator (commonly known as tPA) and streptokinase.
Side effects
Its side effects include nausea, vomiting, and chronic mild fevers (37.2 to 37.8 °C). When used long-term (for approximately 6 to 12 months), there is a risk of the inflammation of one's internal organs, especially the appendix (appendicitis) and liver, as well as failure of the liver and cyanosis. It almost always causes generalized myalgia and fibromyalgia. In some cases, successive organ failure can occur after long-term usage. However, the main risk associated with aminocaproic acid is the increased risk for thrombosis because of the inhibition of fibrinolysis.
Antihemorrhagics (B02)
|
|
Hemostatics
(coagulation) |
Systemic
|
Vitamin K
|
- Phytomenadione (K1)
- Menadione (K3)
|
|
Coagulation factors
|
- intrinsic: IX/Nonacog alfa
- VIII
- extrinsic: VII/Eptacog alfa
- common: X
- II/Thrombin
- I/Fibrinogen
|
|
Other systemic
|
- Etamsylate
- Carbazochrome
- Batroxobin
- thrombopoietin receptor agonist (Romiplostim
- Eltrombopag)
|
|
|
Local
|
- Absorbable gelatin sponge
- Oxidized cellulose
- Tetragalacturonic acid hydroxymethylester
- Thrombin
- Collagen
- Calcium alginate
- Epinephrine/Adrenalone
|
|
|
Antifibrinolytics |
- amino acids (Aminocaproic acid
- Tranexamic acid
- Aminomethylbenzoic acid)
serpins (Aprotinin
- Alfa1 antitrypsin
- C1-inhibitor
- Camostat)
|
|
|
cell/phys (coag, heme, immu, gran), csfs
|
rbmg/mogr/tumr/hist, sysi/epon, btst
|
drug (B1/2/3+5+6), btst, trns
|
|
|
|
References
1. ^Alkjaersig, N et al. (1959). ε-Aminocaproic Acid: an Inhibitor of Plasminogen Activation. J. Biol. Chem. 234: 832-837.
2. ^Kang, Y et al. (1987).Epsilon-aminocaproic Acid for Treatment of Fibrinolysis during Liver Transplantation. Anesthesiology. 66(6): 766–773.
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Predicting Thermodynamic Behaviors of Non-Protein Amino Acids as a Function of Temperature and pH.
- Kitadai N1.
- Origins of life and evolution of the biosphere : the journal of the International Society for the Study of the Origin of Life.Orig Life Evol Biosph.2016 Mar;46(1):3-18. doi: 10.1007/s11084-015-9457-y. Epub 2015 Aug 19.
- Why does life use α-amino acids exclusively as building blocks of proteins To address that fundamental question from an energetic perspective, this study estimated the standard molal thermodynamic data for three non-α-amino acids (β-alanine, γ-aminobutyric acid, and ε-aminocaproic acid) and α
- PMID 26286083
- The Role of Platelets and ε-Aminocaproic Acid in Arthrogryposis, Renal Dysfunction, and Cholestasis (ARC) Syndrome Associated Hemorrhage.
- Weyand AC, Lombel RM, Pipe SW, Shavit JA.
- Pediatric blood & cancer.Pediatr Blood Cancer.2016 Mar;63(3):561-3. doi: 10.1002/pbc.25814. Epub 2015 Oct 27.
- Arthrogryposis, renal dysfunction, and cholestasis (ARC) syndrome is a rare disorder associated with platelet abnormalities resembling gray platelet syndrome. Affected patients have normal platelet numbers but abnormal morphology and function. Bleeding symptomatology ranges from postprocedural to sp
- PMID 26505894
- Aminocaproic acid administration is associated with reduced perioperative blood loss and transfusion in pediatric craniofacial surgery.
- Hsu G1, Taylor JA2, Fiadjoe JE3, Vincent AM3, Pruitt EY3, Bartlett SP2, Stricker PA3.
- Acta anaesthesiologica Scandinavica.Acta Anaesthesiol Scand.2016 Feb;60(2):158-65. doi: 10.1111/aas.12608. Epub 2015 Sep 8.
- BACKGROUND: Severe blood loss is a common complication of craniofacial reconstruction surgery. The antifibrinolytic ε-aminocaproic acid (EACA) reduces transfusion requirements in children undergoing cardiac surgery and in older children undergoing spine surgery. Tranexamic acid (TXA), another antif
- PMID 26346761
Japanese Journal
- Preparation, Physicochemical Properties, and Transfection Activities of Tartaric Acid-Based Cationic Lipids as Effective Nonviral Gene Delivery Vectors
- Preparation, Physicochemical Properties, and Transfection Activities of Tartaric Acid-Based Cationic Lipids as Effective Nonviral Gene Delivery Vectors
- 症例報告 ユニットドーズタイプ精製ヒアルロン酸ナトリウム点眼液によるアレルギー性接触皮膚炎の1例
Related Pictures
★リンクテーブル★
[★]
イプシロンアミノカプロン酸、ε-アミノカプロン酸
- 関
- 6-aminocaproic acid、6-aminohexanoic acid
[★]
6-アミノカプロン酸
- 関
- 6-aminohexanoic acid、epsilon-aminocaproic acid